The Hesistency of Public Toward COVID-19 Vaccine Booster in Indonesia

Palupi Triwahyuni* -  FIK-Universitas Advent Indonesia, Indonesia
Charissa Angie Victorine Simbolon -  FIK-Universitas Advent Indonesia, Indonesia
DOI : 10.33024/mnj.v5i2.7977

Supp. File(s): Instrumen Riset

ABSTRACT

 

Until now, the transmission of the Corona virus disease (COVID-19) is still there. According to the magazine Folkative daily in June 2022 that Omicron BA.4 and BA.5 subvariants were identified enter Indonesia. More than two years into the coronnavirus pandemic, doctors are seeing other viruses, like the flu, act in unusual ways. COVID is making flu and other common viruses act in unfamiliar ways (The Washington Post, June, 2022). The Ministry of Communication and Information of the Republic of Indonesia (KOMINFO, 2022) continuously calls for all people in Indonesia to get a complete dose of 1,2 and booster vaccines. This is to increase immunity so that COVID-19 does not have a severe impact. The booster vaccine can be obtained at Public Health Centers or vaccine centers. This study uses qualitative methods with the phenomenology approach. There are 12 informants on this research which are adults who are willing to become research informants. The data are gathered using a survey with purposive sampling and in-depth interviews. Coallizi's method are used to analyze the interview results. From this research can be found that the informants have knowledge of COVID-19 from pandemic to endemic, know about the type of COVID-19 vaccine, have strong reasons for refusing to give a COVID-19 vaccine booster, believe that a COVID-19 vaccine booster is unnecessary If done, the body already has immunity without having to receive a COVID-19 vaccine booster. This research can be an input to find out more about the public's views on the administration of the COVID-19

 

Keyword: hesistency, COVID-19 vaccine booster

Supplement Files

  1. Cabinet, S. (2020). Gov ’ T To Implement The New Normal Scenario. Sekneg, 1.
  2. Cnn. (2022). Laporan Covid-19 Harian. Https://Www.Who.Int/News-Room/Fact-Sheets/Detail/Autism-Spectrum-Disorders
  3. Di, V. C.-, Semarang, K., & Zeneca, A. (2021). Pendahuluan Diseluruh Dunia Untuk Penerapan Pola Hidup New Normal Perlu Didampingi Peningkatan Kekebalan Program Pengadaan Vaksin Dan Pemberian Vaksinasi Covid-19 Dalam Pemulihan Program Pengadaan Vaksin Dan Pelaksanaan Vaksinasi Peraturan Menteri Kesehat. 3(November), 57–60.
  4. Disemadi, H. S., & Pardede, T. S. (2021). Problematika Pemberian Sanksi Terhadap Penolakan Vaksinasi Covid-19: Suatu Kajian Perspektif Ham. Jurnal Supremasi, 11(2), 107–119. Https://Doi.Org/10.35457/Supremasi.V11i2.1442
  5. Eridani, S. (2011). M Er Ci Al Us E On Om M Er Ci Al Us E Genetic Factors. 3(2), 371–380. Https://Doi.Org/10.4081/Idr.2020
  6. Fauzan, A. C., & Hikmah, K. (2022). Implementasi Algoritma Naive Bayes Dalam Analisis Pendahuluan Pada Akhir Tahun 2019 , Terdapat Wabah Covid-19 Di China Tepatnya Di Wuhan Provinsi Hubei . Virus Ini Merupakan Virus Yang Sangat Mudah Menyebar Sehingga Who ( Word Health Organization ) Meneta. 7(2), 122–128.
  7. Gunawan, R., & Toni, A. (2022). Strategi Komunikasi Publik Kemenkes Ri Dalam Membangun Kesadaran Dan Partisipasi Masyarakat Untuk Vaksinasi Covid-19 Melalui Model Sostac. Jurnal Komunikasi, 16(1), 52–73. Https://Doi.Org/10.21107/Ilkom.V16i1.13817
  8. Hiola, A. N. A., Asrifuddin, A., Langi, F. L. F. G., Kesehatan, F., Universitas, M., & Ratulangi, S. (2022). Hubungan Antara Upaya Pencegahan Covid-19 Dengan Angka Konfirmasi Positif Covid- 19 Di Indonesia Pendahuluan Tahun 2019 , Virus Corona Jenis Baru Yang Ditemukan Di Wuhan , China Dikenal Dengan Nama Penyakit Coronavirus Disease -2019 Memiliki Kemampuan Jug. Kesmas, 11(2), 135–142.
  9. Irwan, R., Saputri, M. E., & Wowor, T. J. F. (2022). Faktor-Faktor Yang Berhubungan Dengan Vaksinasi Covid-19 Dikomplek Villa Pertiwi Depok Jawa Barat. Malahayati Nursing Journal, 4(6), 1359–1369. Https://Doi.Org/10.33024/Mnj.V4i6.6237
  10. Junaedi, D., Arsyad, M. R., Salistia, F., & Romli, M. (2021). Menguji Efektivitas Vaksinasi Covid-19 Di Indonesia. Reslaj : Religion Education Social Laa Roiba Journal, 4(1), 120–143. Https://Doi.Org/10.47467/Reslaj.V4i1.537
  11. Juni Ahyar Dan Muzir. (2019). Kamus Istilah Ilmiah : Dilengkapi Kata Baku Dan Tidak Baku, Unsur Serapan, Singkatan Dan Akronim, Dan Peribahasa. In Buku Elektronik. Https://Www.Google.Co.Id/Books/Edition/Kamus_Istilah_Ilmiah_Dilengkapi_Kata_Bak/Tlbpdwaaqbaj?Hl=Id&Gbpv=1
  12. Kominfo. (2022). Situasi Covid-19 Di Indonesia (Update Per 2 Juli 2022). Covid19.Go.Id, 1. Https://Covid19.Go.Id/Artikel/2022/03/02/Situasi-Covid-19-Di-Indonesia-Update-2-Maret-2022
  13. Makarim. (2017). Kewajiban Imunisasi Dasar, Manfaat Dan Keamanan. Riptek, 2(2), 87–96. Https://Riptek.Semarangkota.Go.Id/Index.Php/Riptek/Article/View/30/31
  14. Moudy, J., & Syakurah, R. A. (2020). Pengetahuan Terkait Usaha Pencegahan Coronavirus Disease (Covid-19) Di Indonesia. Higeia Journal Of Public Health Research And Development, 4(3), 333–346.
  15. Mursinah, Susanti, N., & Herna. (2020). Penolakan Vaksin Di Beberapa Negara Asia Dan Ancaman Penyakit Yang Dapat Dicegah Dengan Imunisasi. Prosiding Seminar Nasional Sains, 1(1), 128–134.
  16. Newyork.Pdf. (N.D.). New York.
  17. Putri, R. N. (2020). Indonesia Dalam Menghadapi Pandemi Covid-19. Jurnal Ilmiah Universitas Batanghari Jambi, 20(2), 705. Https://Doi.Org/10.33087/Jiubj.V20i2.1010
  18. Rahayu, R. N., & Sensusiyati. (2020). Analisis Berita Hoax Covid - 19 Di Media Sosial Di Indonesia. Jurnal Ekonomi, Sosial, & Humaniora, 1(9), 63.
  19. Rizki, M., Prasetyanto, D., & Maulana, A. (2021). Kesehatan Mental Dan Perubahan Aktivitas-Perjalanan Saat Pandemi Covid-19 Di Indonesia. Jurnal Rekayasa Hijau, 5(2), 125–135. Https://Doi.Org/10.26760/Jrh.V5i2.125-135
  20. Rukajat, A. (2018). Pendekatan Penelitian Kualitatif (1st Ed.). Deepublish.
  21. Rulinawaty, R., Sjuchro, D. W., Syahrial, S., Badollahi, M. Z., & Hussain, Z. (2022). Online News Regarding The Spread Of The Omicron Variant In Southeast Asia. Jurnal Studi Komunikasi (Indonesian Journal Of Communications Studies), 6(2), 440–452. Https://Doi.Org/10.25139/Jsk.V6i2.4865
  22. Shah, W., Hillman, T., Playford, E. D., & Hishmeh, L. (2021). Managing The Long Term Effects Of Covid-19: Summary Of Nice, Sign, And Rcgp Rapid Guideline. The Bmj, 372, 10–13. Https://Doi.Org/10.1136/Bmj.N136
  23. Sulistyawati, F., & Widarini, N. P. (2022). Tren Menolak Vaksin. Indonesian Journal For Health Sciences, 6(2), 15–23.
  24. Telaumbanua, D. (2020). Urgensi Pembentukan Aturan Terkait Pencegahan Covid-19 Di Indonesia. Qalamuna: Jurnal Pendidikan, Sosial, Dan Agama, 12(01), 59–70. Https://Doi.Org/10.37680/Qalamuna.V12i01.290
  25. Valerio, V., Rampakakis, E., Zanos, T. P., Levy, T. J., Shen, H. C., Mcdonald, E. G., Frenette, C., Bernatsky, S., Hudson, M., Ward, B. J., & Colmegna, I. (2022). High Frequency Of Covid-19 Vaccine Hesitancy Among Canadians Immunized For Influenza: A Cross-Sectional Survey. Vaccines, 10(9), 1–15. Https://Doi.Org/10.3390/Vaccines10091514
  26. Who. (2022). Good Practice Statement On The Use Of Second Booster Doses For Covid-19 Vaccines (Issue Oktober).
  27. Zendrato, W. (2020). Gerakan Mencegah Daripada Mengobati Terhadap Pandemi Covid-19. Jurnal Education And Development, 8(2), 242–248.